Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing
Conferences
Reisman, S; Halabi, D; Miller, S; Rice, G; Sangvai, N; Gersbach, C
Published in: MOLECULAR THERAPY
April 28, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Reisman, S., Halabi, D., Miller, S., Rice, G., Sangvai, N., & Gersbach, C. (2025). Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing. In MOLECULAR THERAPY (Vol. 33).
Reisman, Samuel, Dahlia Halabi, Samantha Miller, Grayson Rice, Nicholas Sangvai, and Charles Gersbach. “Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing.” In MOLECULAR THERAPY, Vol. 33, 2025.
Reisman S, Halabi D, Miller S, Rice G, Sangvai N, Gersbach C. Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing. In: MOLECULAR THERAPY. 2025.
Reisman, Samuel, et al. “Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.
Reisman S, Halabi D, Miller S, Rice G, Sangvai N, Gersbach C. Direct Reprogramming of Primary Human Astrocytes to Functional Neurons with CRISPR-Based Epigenome Editing. MOLECULAR THERAPY. 2025.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics